Herantis Pharma (Finland) Market Value
| HRTIS Stock | EUR 1.49 0.07 4.49% |
| Symbol | Herantis |
Herantis Pharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Herantis Pharma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Herantis Pharma.
| 01/12/2022 |
| 12/27/2024 |
If you would invest 0.00 in Herantis Pharma on January 12, 2022 and sell it all today you would earn a total of 0.00 from holding Herantis Pharma Oyj or generate 0.0% return on investment in Herantis Pharma over 1080 days. Herantis Pharma is related to or competes with Sampo Oyj, UPM Kymmene, Wartsila Oyj, Elisa Oyj, and Kesko Oyj. Herantis Pharma Oyj, a drug development company, focuses on developing regenerative therapeutics More
Herantis Pharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Herantis Pharma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Herantis Pharma Oyj upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.43 | |||
| Information Ratio | 0.0233 | |||
| Maximum Drawdown | 11.6 | |||
| Value At Risk | (4.17) | |||
| Potential Upside | 5.19 |
Herantis Pharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Herantis Pharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Herantis Pharma's standard deviation. In reality, there are many statistical measures that can use Herantis Pharma historical prices to predict the future Herantis Pharma's volatility.| Risk Adjusted Performance | 0.035 | |||
| Jensen Alpha | 0.0903 | |||
| Total Risk Alpha | 0.0098 | |||
| Sortino Ratio | 0.0262 | |||
| Treynor Ratio | (0.43) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Herantis Pharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Herantis Pharma Oyj Backtested Returns
Herantis Pharma is very risky at the moment. Herantis Pharma Oyj holds Efficiency (Sharpe) Ratio of 0.0604, which attests that the entity had a 0.0604% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Herantis Pharma Oyj, which you can use to evaluate the volatility of the firm. Please check out Herantis Pharma's Market Risk Adjusted Performance of (0.42), downside deviation of 2.43, and Risk Adjusted Performance of 0.035 to validate if the risk estimate we provide is consistent with the expected return of 0.17%. Herantis Pharma has a performance score of 4 on a scale of 0 to 100. The company retains a Market Volatility (i.e., Beta) of -0.2, which attests to not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Herantis Pharma are expected to decrease at a much lower rate. During the bear market, Herantis Pharma is likely to outperform the market. Herantis Pharma Oyj right now retains a risk of 2.82%. Please check out Herantis Pharma value at risk, as well as the relationship between the skewness and day median price , to decide if Herantis Pharma will be following its current trending patterns.
Auto-correlation | -0.05 |
Very weak reverse predictability
Herantis Pharma Oyj has very weak reverse predictability. Overlapping area represents the amount of predictability between Herantis Pharma time series from 12th of January 2022 to 6th of July 2023 and 6th of July 2023 to 27th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Herantis Pharma Oyj price movement. The serial correlation of -0.05 indicates that only as little as 5.0% of current Herantis Pharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.05 | |
| Spearman Rank Test | -0.06 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Herantis Pharma Oyj lagged returns against current returns
Autocorrelation, which is Herantis Pharma stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Herantis Pharma's stock expected returns. We can calculate the autocorrelation of Herantis Pharma returns to help us make a trade decision. For example, suppose you find that Herantis Pharma has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Herantis Pharma regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Herantis Pharma stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Herantis Pharma stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Herantis Pharma stock over time.
Current vs Lagged Prices |
| Timeline |
Herantis Pharma Lagged Returns
When evaluating Herantis Pharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Herantis Pharma stock have on its future price. Herantis Pharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Herantis Pharma autocorrelation shows the relationship between Herantis Pharma stock current value and its past values and can show if there is a momentum factor associated with investing in Herantis Pharma Oyj.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Herantis Stock
Herantis Pharma financial ratios help investors to determine whether Herantis Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Herantis with respect to the benefits of owning Herantis Pharma security.